Beta 2-microglobulin can be a disease activity marker in systemic lupus erythematosus.
Kim, HA; Jeon, JY; Yoon, JM; Suh, CH
The American journal of the medical sciences, 339(4):337-340, 2010
The American journal of the medical sciences
BACKGROUND: To investigate the clinical significance of beta2-microglobulin in Korean patients with systemic lupus erythematosus (SLE).
METHODS: Blood samples were collected from patients with SLE (n = 100) and normal healthy controls (n = 50). The level of beta2-microglobulin was investigated by enzyme-linked immunosorbent assay. Serial samples from SLE patients were collected at 4.2 +/- 2.6 months after first sampling.
RESULTS: The beta2-microglobulin levels of the SLE patients (2.64 +/- 0.11 microg/mL) were higher than the normal controls (2.14 +/- 0.04 microg/mL, P < 0.001). The patients with SLE with serositis, oral ulcer, or lupus nephritis had significantly higher beta2-microglobulin levels than those without, respectively. A significant correlation was found between the beta2-microglobulin level and each of anti-dsDNA antibody, hemoglobin, complement, and SLE Disease Activity Index. In sequential sampling of patients with SLE, a positive correlation was found between the change of the SLE Disease Activity Index and the change of the beta2-microglobulin levels.
CONCLUSIONS: These data suggest that the measurement of beta2-microglobulin seem to be a useful addition to the laboratory tests that can help in assessment of disease activity of SLE.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Total Visit :3,477,378
Total Download :1,455,856
Today View :1,725
Ajou University Medical Information & Media Center 164 Worldcup-ro Yeongtong-gu Suwon 16499 Korea / TEL : 031-219-5312 / FAX : 031-219-5314 Copyright (c) Ajou University Medical Information & Media Center All Rights Reserved. AJOU Open Repository는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.